Summit Therapeutics Inc. (SMMT) NASDAQ
$3.51 - (-)
Market Cap: $2.46B
As of 04/19/24 03:59 PM EDT. Market closed.
Summit Therapeutics Inc. (SMMT)
NASDAQ
$3.51
- (-)
Market Cap: $2.46B
As of 04/19/24 03:59 PM EDT. Market closed.
Add to Portfolio
summit is a uk company focused on the discovery and development of novel drug candidates to treat areas of high unmet medical need. our strategy focuses on two therapy areas: duchenne muscular dystrophy, a fatal genetic muscle wasting disease and the infectious disease caused by the bacteria c. ... read more
summit is a uk company focused on the discovery and development of novel drug candidates to treat areas of high unmet medical need. our strategy focuses on two therapy areas: duchenne muscular dystrophy, a fatal genetic muscle wasting disease and the infectious disease caused by the bacteria c. difficile. read less
COMPANY PROFILE
Sector
Industry
PRICE CHART FOR SUMMIT THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.50
Previous Close
$3.51
Days Range
$3.50 - $3.66
52 week range
$1.30 - $5.22
Volume
1,727,400
Avg. Volume (30 days)
2,074,256
Market Cap
$2.46B
Dividend Yield
-
P/E
(4.12)
Shares Outstanding
701,703,363
Open
$3.50
Previous Close
$3.51
Days Range
$3.50 - $3.66
52 week range
$1.30 - $5.22
Volume
1,727,400
Avg. Volume (30 days)
2,074,256
Market Cap
$2.46B
Dividend Yield
-
P/E
(4.12)
Shares Outstanding
701,703,363
FINANCIAL STATEMENTS FOR SUMMIT THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR SUMMIT THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Zanganeh Mahkam | Chief Executive Officer | Mar 27, 2024 | Buy | $3.71 | 20,000 | 74,200 | 50,000 | Mar 27, 2024, 08:28 PM |
| Zanganeh Mahkam | Chief Executive Officer | Mar 26, 2024 | Buy | $3.75 | 30,000 | 112,500 | 30,000 | Mar 27, 2024, 08:28 PM |
| Zanganeh Mahkam | Chief Executive Officer | Mar 27, 2024 | Buy | $3.72 | 34,321 | 127,674 | 24,923,800 | Mar 27, 2024, 08:28 PM |
| Zanganeh Mahkam | Chief Executive Officer | Mar 27, 2024 | Buy | $3.72 | 26,000 | 96,720 | 520,814 | Mar 27, 2024, 08:28 PM |
| Dhingra Ankur | Chief Financial Officer | Mar 26, 2024 | Buy | $3.75 | 100,000 | 375,000 | 354,958 | Mar 27, 2024, 08:27 PM |
| Zanganeh Mahkam | Chief Executive Officer | Dec 12, 2023 | Buy | $2.07 | 5,000 | 10,350 | 494,814 | Dec 13, 2023, 05:11 PM |
| Zanganeh Mahkam | Chief Executive Officer | Dec 11, 2023 | Option Exercise | $1.58 | 315,681 | 498,776 | 24,889,479 | Dec 13, 2023, 05:11 PM |
| Zanganeh Mahkam | Chief Executive Officer | Dec 11, 2023 | Option Exercise | $1.44 | 489,814 | 705,332 | 489,814 | Dec 13, 2023, 05:11 PM |
| Dhingra Ankur | Chief Financial Officer | Dec 13, 2023 | Buy | $2.17 | 20,400 | 44,254 | 254,958 | Dec 13, 2023, 04:49 PM |
| Soni Manmeet Singh | Chief Operating Officer | Oct 13, 2023 | Buy | $1.68 | 2,976,190 | 4,999,999 | 2,976,190 | Oct 16, 2023, 04:06 PM |
| Zanganeh Mahkam | Co-CEO & President | Mar 08, 2023 | Buy | $1.05 | 16,778,415 | 17,617,335 | 24,573,798 | Mar 13, 2023, 06:27 PM |
| Zanganeh Mahkam | Co-CEO & President | Mar 08, 2023 | Buy | $1.05 | 6,748,629 | 7,086,060 | 9,884,095 | Mar 13, 2023, 06:27 PM |
| Zanganeh Mahkam | Co-Chief Executive Officer | Mar 08, 2023 | Buy | $1.05 | 6,748,629 | 7,086,060 | 9,884,095 | Mar 08, 2023, 09:31 PM |
| Zanganeh Mahkam | Co-Chief Executive Officer | Mar 08, 2023 | Buy | $1.05 | 804,672 | 844,906 | 1,178,529 | Mar 08, 2023, 09:31 PM |
| Zanganeh Mahkam | Co-Chief Executive Officer | Mar 08, 2023 | Buy | $1.05 | 15,973,743 | 16,772,429 | 23,395,269 | Mar 08, 2023, 09:31 PM |
| Dhingra Ankur | Chief Financial Officer | Mar 07, 2023 | Buy | $1.05 | 196,362 | 206,180 | 234,558 | Mar 08, 2023, 05:24 PM |
| Dhingra Ankur | Chief Financial Officer | Aug 16, 2022 | Buy | $0.97 | 24,658 | 23,918 | 38,196 | Mar 08, 2023, 04:58 PM |
| Dhingra Ankur | Chief Financial Officer | Aug 16, 2022 | Buy | $0.97 | 13,027 | 12,636 | 39,527 | Mar 08, 2023, 04:58 PM |
| DUGGAN ROBERT W | Chief Executive Officer | Mar 06, 2023 | Buy | $1.05 | 376,489,880 | 395,314,356 | 552,354,161 | Mar 08, 2023, 04:12 PM |
| DUGGAN ROBERT W | Chief Executive Officer | Aug 16, 2022 | Buy | $0.97 | 94,849,203 | 92,003,730 | 162,532,792 | Aug 18, 2022, 04:38 PM |
| Zanganeh Maky | Co-CEO & President | Aug 16, 2022 | Buy | $0.97 | 1,030,925 | 999,997 | 3,135,466 | Aug 18, 2022, 04:36 PM |
| Zanganeh Maky | Co-CEO & President | Aug 16, 2022 | Buy | $0.97 | 4,593,777 | 4,455,964 | 7,061,557 | Aug 18, 2022, 04:36 PM |
| Zanganeh Maky | Co-CEO & President | Aug 16, 2022 | Buy | $0.97 | 184,430 | 178,897 | 359,969 | Aug 18, 2022, 04:36 PM |
| Dhingra Ankur | Chief Financial Officer | Aug 16, 2022 | Buy | $0.97 | 24,658 | 23,918 | 38,196 | Aug 17, 2022, 04:49 PM |
| Dhingra Ankur | Chief Financial Officer | Aug 16, 2022 | Buy | $0.97 | 11,557 | 11,210 | 38,057 | Aug 17, 2022, 04:49 PM |
| DUGGAN ROBERT W | Chief Executive Officer | May 12, 2021 | Buy | $5.24 | 11,365,921 | 59,557,423 | 67,662,454 | May 14, 2021, 04:39 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 30, 2020 | Option Exercise | $1.79 | 13,713 | 24,546 | 13,713 | Dec 01, 2020, 07:45 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 27, 2020 | Option Exercise | $1.86 | 29,569 | 55,089 | 29,569 | Dec 01, 2020, 07:45 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 30, 2020 | Sale | $4.44 | 13,713 | 60,886 | 0 | Dec 01, 2020, 07:45 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 27, 2020 | Sale | $4.39 | 29,569 | 129,808 | 0 | Dec 01, 2020, 07:45 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 25, 2020 | Option Exercise | $1.92 | 12,070 | 23,174 | 12,070 | Nov 25, 2020, 07:51 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 24, 2020 | Option Exercise | $1.92 | 11,374 | 21,838 | 11,374 | Nov 25, 2020, 07:51 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 23, 2020 | Option Exercise | $1.92 | 6,987 | 13,415 | 6,987 | Nov 25, 2020, 07:51 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 25, 2020 | Sale | $4.32 | 12,070 | 52,142 | 0 | Nov 25, 2020, 07:51 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 24, 2020 | Sale | $4.21 | 11,374 | 47,885 | 0 | Nov 25, 2020, 07:51 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 23, 2020 | Sale | $4.40 | 6,987 | 30,743 | 0 | Nov 25, 2020, 07:51 PM |
| DUGGAN ROBERT W | Chief Executive Officer | Nov 06, 2020 | Buy | $3.34 | 14,071,856 | 46,999,998 | 56,296,533 | Nov 10, 2020, 04:25 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Zanganeh Mahkam | Chief Executive Officer | 03/27/2024 | 74,200 |
| Zanganeh Mahkam | Chief Executive Officer | 03/26/2024 | 112,500 |
| Zanganeh Mahkam | Chief Executive Officer | 03/27/2024 | 127,674 |
| Zanganeh Mahkam | Chief Executive Officer | 03/27/2024 | 96,720 |
| Dhingra Ankur | Chief Financial Officer | 03/26/2024 | 375,000 |
| Zanganeh Mahkam | Chief Executive Officer | 12/12/2023 | 10,350 |
| Zanganeh Mahkam | Chief Executive Officer | 12/11/2023 | 498,776 |
| Zanganeh Mahkam | Chief Executive Officer | 12/11/2023 | 705,332 |
| Dhingra Ankur | Chief Financial Officer | 12/13/2023 | 44,254 |
| Soni Manmeet Singh | Chief Operating Officer | 10/13/2023 | 4,999,999 |
| Zanganeh Mahkam | Co-CEO & President | 03/08/2023 | 17,617,335 |
| Zanganeh Mahkam | Co-CEO & President | 03/08/2023 | 7,086,060 |
| Zanganeh Mahkam | Co-Chief Executive Officer | 03/08/2023 | 7,086,060 |
| Zanganeh Mahkam | Co-Chief Executive Officer | 03/08/2023 | 844,906 |
| Zanganeh Mahkam | Co-Chief Executive Officer | 03/08/2023 | 16,772,429 |
| Dhingra Ankur | Chief Financial Officer | 03/07/2023 | 206,180 |
| Dhingra Ankur | Chief Financial Officer | 08/16/2022 | 23,918 |
| Dhingra Ankur | Chief Financial Officer | 08/16/2022 | 12,636 |
| DUGGAN ROBERT W | Chief Executive Officer | 03/06/2023 | 395,314,356 |
| DUGGAN ROBERT W | Chief Executive Officer | 08/16/2022 | 92,003,730 |
| Zanganeh Maky | Co-CEO & President | 08/16/2022 | 999,997 |
| Zanganeh Maky | Co-CEO & President | 08/16/2022 | 4,455,964 |
| Zanganeh Maky | Co-CEO & President | 08/16/2022 | 178,897 |
| Dhingra Ankur | Chief Financial Officer | 08/16/2022 | 23,918 |
| Dhingra Ankur | Chief Financial Officer | 08/16/2022 | 11,210 |
| DUGGAN ROBERT W | Chief Executive Officer | 05/12/2021 | 59,557,423 |
| Powell David Jonathan | Chief Scientific Officer | 11/30/2020 | 24,546 |
| Powell David Jonathan | Chief Scientific Officer | 11/27/2020 | 55,089 |
| Powell David Jonathan | Chief Scientific Officer | 11/30/2020 | 60,886 |
| Powell David Jonathan | Chief Scientific Officer | 11/27/2020 | 129,808 |
| Powell David Jonathan | Chief Scientific Officer | 11/25/2020 | 23,174 |
| Powell David Jonathan | Chief Scientific Officer | 11/24/2020 | 21,838 |
| Powell David Jonathan | Chief Scientific Officer | 11/23/2020 | 13,415 |
| Powell David Jonathan | Chief Scientific Officer | 11/25/2020 | 52,142 |
| Powell David Jonathan | Chief Scientific Officer | 11/24/2020 | 47,885 |
| Powell David Jonathan | Chief Scientific Officer | 11/23/2020 | 30,743 |
| DUGGAN ROBERT W | Chief Executive Officer | 11/06/2020 | 46,999,998 |
Load More Insider Transactions
FUNDS WITH A POSITION IN SUMMIT THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 9,759,383 | 0.00065% | 8.72% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 3,085,666 | 0.00084% | 4.35% | Other |
| ALPS ADVISORS INC | 532,406 | 0.01% | 3.39% | Other |
| ALPINE GLOBAL MANAGEMENT, LLC | 30,000 | 0.03% | No change | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR SUMMIT THERAPEUTICS INC
STOCK BUYBACKS FOR SUMMIT THERAPEUTICS INC
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.54%
1Q
06/30/2023
0.54%
2Q
BUYBACK ANNOUNCEMENT(S) FOR SUMMIT THERAPEUTICS INC
LOADING...